Works by Valk, L. C.

Results: 2
    1

    Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14500-6
    By:
    • Russ, E.;
    • Ziemons, J.;
    • Hillege, L. E.;
    • van Kuijk, S. M. J.;
    • de Jong, E. M.;
    • Elbers, C.;
    • Deenen, M. J.;
    • Borghuis, L. H.;
    • Böhm, T. M. M.;
    • Kristen, P.;
    • Valk, L. C.;
    • van Hellemond, I. E. G.;
    • Vestjens, H.;
    • Dietvorst, A.;
    • Baars, A.;
    • Goosens, A. N. M.;
    • Vermeulen, L.;
    • Buffart, T. E.;
    • de Vos-Geelen, J.;
    • Penders, J.
    Publication type:
    Article
    2